Difficulty in establishing sirolimus therapy as a cause of interstitial pneumonitis in renal-transplant recipients

CHIH-YUAN LEEMENG-KUN TSAIPO-HUANG LEEHuang C.-C.Chen S.-F.2022-01-072022-01-0720040929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-7044246020&partnerID=40&md5=ee0993f02ff30b5e460ba4037d8711f5https://scholars.lib.ntu.edu.tw/handle/123456789/591873[SDGs]SDG3azathioprine; beta adrenergic receptor blocking agent; cotrimoxazole; cyclosporin; dipeptidyl carboxypeptidase inhibitor; fibric acid derivative; methylprednisolone; prednisolone; rapamycin; immunosuppressive agent; rapamycin; case report; diagnostic procedure; differential diagnosis; drug blood level; drug megadose; human; interstitial pneumonia; kidney graft rejection; kidney transplantation; letter; lung biopsy; opportunistic infection; chemically induced disorder; immunology; interstitial lung disease; note; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; SirolimusDifficulty in establishing sirolimus therapy as a cause of interstitial pneumonitis in renal-transplant recipientsletter153619502-s2.0-7044246020